{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T09:28:38Z","timestamp":1766136518070},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Semin Immunopathol"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s00281-014-0444-6","type":"journal-article","created":{"date-parts":[[2014,9,11]],"date-time":"2014-09-11T06:00:22Z","timestamp":1410415222000},"page":"541-551","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Use of animal models in elucidating disease pathogenesis in IBD"],"prefix":"10.1007","volume":"36","author":[{"given":"Puja Vora","family":"Khanna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Quan","family":"Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talin","family":"Haritunians","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dermot Patrick","family":"McGovern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Targan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,12]]},"reference":[{"key":"444_CR1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature11582","volume":"491","author":"L Jostins","year":"2012","unstructured":"Jostins L, Ripke S, Weersma RK et al (2012) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491:119\u201324","journal-title":"Nature"},{"key":"444_CR2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nature06245","volume":"449","author":"L Dethlefsen","year":"2007","unstructured":"Dethlefsen L, McFall-Ngai M, Relman DA (2007) An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 449:811\u20138","journal-title":"Nature"},{"key":"444_CR3","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nature06244","volume":"449","author":"PJ Turnbaugh","year":"2007","unstructured":"Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI (2007) The human microbiome project. Nature 449:804\u201310","journal-title":"Nature"},{"key":"444_CR4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature08821","volume":"464","author":"J Qin","year":"2010","unstructured":"Qin J, Li R, Raes J et al (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59\u201365","journal-title":"Nature"},{"key":"444_CR5","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1073\/pnas.1116053109","volume":"109","author":"S Greenblum","year":"2012","unstructured":"Greenblum S, Turnbaugh PJ, Borenstein E (2012) Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease. Proc Natl Acad Sci USA 109:594\u20139","journal-title":"Proc Natl Acad Sci USA"},{"key":"444_CR6","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature11550","volume":"489","author":"CA Lozupone","year":"2012","unstructured":"Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R (2012) Diversity, stability and resilience of the human gut microbiota. Nature 489:220\u201330","journal-title":"Nature"},{"key":"444_CR7","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature07540","volume":"457","author":"PJ Turnbaugh","year":"2009","unstructured":"Turnbaugh PJ, Hamady M, Yatsunenko T et al (2009) A core gut microbiome in obese and lean twins. Nature 457:480\u20134","journal-title":"Nature"},{"key":"444_CR8","doi-asserted-by":"crossref","first-page":"13780","DOI":"10.1073\/pnas.0706625104","volume":"104","author":"DN Frank","year":"2007","unstructured":"Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 104:13780\u20135","journal-title":"Proc Natl Acad Sci USA"},{"key":"444_CR9","doi-asserted-by":"crossref","first-page":"e80702","DOI":"10.1371\/journal.pone.0080702","volume":"8","author":"M Tong","year":"2013","unstructured":"Tong M, Li X, Wegener Parfrey L et al (2013) A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel disease. PLoS One 8:e80702","journal-title":"PLoS One"},{"key":"444_CR10","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.chom.2014.02.005","volume":"15","author":"D Gevers","year":"2014","unstructured":"Gevers D, Kugathasan S, Denson LA et al (2014) The treatment-naive microbiome in new-onset Crohn\u2019s disease. Cell Host Microbe 15:382\u201392","journal-title":"Cell Host Microbe"},{"key":"444_CR11","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35079114","volume":"411","author":"Y Ogura","year":"2001","unstructured":"Ogura Y, Bonen DK, Inohara N et al (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn\u2019s disease. Nature 411:603\u20136","journal-title":"Nature"},{"key":"444_CR12","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","volume":"411","author":"JP Hugot","year":"2001","unstructured":"Hugot JP, Chamaillard M, Zouali H et al (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn\u2019s disease. Nature 411:599\u2013603","journal-title":"Nature"},{"key":"444_CR13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/379821a0","volume":"379","author":"JP Hugot","year":"1996","unstructured":"Hugot JP, Laurent-Puig P, Gower-Rousseau C et al (1996) Mapping of a susceptibility locus for Crohn\u2019s disease on chromosome 16. Nature 379:821\u20133","journal-title":"Nature"},{"key":"444_CR14","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ng.717","volume":"42","author":"A Franke","year":"2010","unstructured":"Franke A, McGovern DP, Barrett JC et al (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn\u2019s disease susceptibility loci. Nat Genet 42:1118\u201325","journal-title":"Nat Genet"},{"key":"444_CR15","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ng.175","volume":"40","author":"JC Barrett","year":"2008","unstructured":"Barrett JC, Hansoul S, Nicolae DL et al (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn\u2019s disease. Nat Genet 40:955\u201362","journal-title":"Nat Genet"},{"key":"444_CR16","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/ng.952","volume":"43","author":"MA Rivas","year":"2011","unstructured":"Rivas MA, Beaudoin M, Gardet A et al (2011) Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 43:1066\u201373","journal-title":"Nat Genet"},{"key":"444_CR17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1196\/annals.1326.020","volume":"1072","author":"TA Kufer","year":"2006","unstructured":"Kufer TA, Banks DJ, Philpott DJ (2006) Innate immune sensing of microbes by Nod proteins. Ann N Y Acad Sci 1072:19\u201327","journal-title":"Ann N Y Acad Sci"},{"key":"444_CR18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ni.1823","volume":"11","author":"LH Travassos","year":"2010","unstructured":"Travassos LH, Carneiro LA, Ramjeet M et al (2010) Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol 11:55\u201362","journal-title":"Nat Immunol"},{"key":"444_CR19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nm.2069","volume":"16","author":"R Cooney","year":"2010","unstructured":"Cooney R, Baker J, Brain O et al (2010) NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med 16:90\u20137","journal-title":"Nat Med"},{"key":"444_CR20","doi-asserted-by":"crossref","first-page":"15813","DOI":"10.1073\/pnas.0907722106","volume":"106","author":"T Petnicki-Ocwieja","year":"2009","unstructured":"Petnicki-Ocwieja T, Hrncir T, Liu YJ et al (2009) Nod2 is required for the regulation of commensal microbiota in the intestine. Proc Natl Acad Sci USA 106:15813\u20138","journal-title":"Proc Natl Acad Sci USA"},{"key":"444_CR21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ibd.21339","volume":"17","author":"DN Frank","year":"2011","unstructured":"Frank DN, Robertson CE, Hamm CM et al (2011) Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 17:179\u201384","journal-title":"Inflamm Bowel Dis"},{"key":"444_CR22","doi-asserted-by":"crossref","first-page":"e26284","DOI":"10.1371\/journal.pone.0026284","volume":"7","author":"E Li","year":"2012","unstructured":"Li E, Hamm CM, Gulati AS et al (2012) Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition. PLoS One 7:e26284","journal-title":"PLoS One"},{"key":"444_CR23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cgh.2006.12.027","volume":"5","author":"JF Rodemann","year":"2007","unstructured":"Rodemann JF, Dubberke ER, Reske KA, da Seo H, Stone CD (2007) Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc 5:339\u201344","journal-title":"Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc"},{"key":"444_CR24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/imr.12193","volume":"260","author":"W Strober","year":"2014","unstructured":"Strober W, Asano N, Fuss I, Kitani A, Watanabe T (2014) Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn\u2019s disease. Immunol Rev 260:249\u201360","journal-title":"Immunol Rev"},{"key":"444_CR25","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1136\/gut.2010.216259","volume":"60","author":"A Rehman","year":"2011","unstructured":"Rehman A, Sina C, Gavrilova O et al (2011) Nod2 is essential for temporal development of intestinal microbial communities. Gut 60:1354\u201362","journal-title":"Gut"},{"key":"444_CR26","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/ibd.22848","volume":"18","author":"JM Natividad","year":"2012","unstructured":"Natividad JM, Petit V, Huang X et al (2012) Commensal and probiotic bacteria influence intestinal barrier function and susceptibility to colitis in Nod1\u2212\/\u2212; Nod2\u2212\/\u2212 mice. Inflamm Bowel Dis 18:1434\u201346","journal-title":"Inflamm Bowel Dis"},{"key":"444_CR27","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1074\/jbc.270.9.4640","volume":"270","author":"RJ Kelly","year":"1995","unstructured":"Kelly RJ, Rouquier S, Giorgi D, Lennon GG, Lowe JB (1995) Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J Biol Chem 270:4640\u20139","journal-title":"J Biol Chem"},{"key":"444_CR28","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/molbev\/msp108","volume":"26","author":"A Ferrer-Admetlla","year":"2009","unstructured":"Ferrer-Admetlla A, Sikora M, Laayouni H et al (2009) A natural history of FUT2 polymorphism in humans. Mol Biol Evol 26:1993\u20132003","journal-title":"Mol Biol Evol"},{"key":"444_CR29","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1093\/hmg\/ddq248","volume":"19","author":"DP McGovern","year":"2010","unstructured":"McGovern DP, Jones MR, Taylor KD et al (2010) Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn\u2019s disease. Hum Mol Genet 19:3468\u20133476","journal-title":"Hum Mol Genet"},{"key":"444_CR30","doi-asserted-by":"crossref","first-page":"19030","DOI":"10.1073\/pnas.1106408108","volume":"108","author":"P Rausch","year":"2011","unstructured":"Rausch P, Rehman A, Kunzel S et al (2011) Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype. Proc Natl Acad Sci USA 108:19030\u20135","journal-title":"Proc Natl Acad Sci USA"},{"key":"444_CR31","first-page":"610","volume":"6","author":"M Tong","year":"2014","unstructured":"Tong M, McHardy I, Ruegger P et al (2014) Reprograming of gut microbiome energy metabolism by the FUT2 Crohn\u2019s disease risk polymorphism. ISME J 6:610\u2013618","journal-title":"ISME J"},{"key":"444_CR32","doi-asserted-by":"crossref","first-page":"e20113","DOI":"10.1371\/journal.pone.0020113","volume":"6","author":"P Wacklin","year":"2011","unstructured":"Wacklin P, Makivuokko H, Alakulppi N et al (2011) Secretor genotype (FUT2 gene) is strongly associated with the composition of Bifidobacteria in the human intestine. PLoS One 6:e20113","journal-title":"PLoS One"},{"key":"444_CR33","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/gb-2012-13-9-r79","volume":"13","author":"XC Morgan","year":"2012","unstructured":"Morgan XC, Tickle TL, Sokol H et al (2012) Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 13:R79","journal-title":"Genome Biol"},{"key":"444_CR34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/ng1954","volume":"39","author":"J Hampe","year":"2007","unstructured":"Hampe J, Franke A, Rosenstiel P et al (2007) A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn\u2019s disease in ATG16L1. Nat Genet 39:207\u201311","journal-title":"Nat Genet"},{"key":"444_CR35","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/ng2032","volume":"39","author":"JD Rioux","year":"2007","unstructured":"Rioux JD, Xavier RJ, Taylor KD et al (2007) Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 39:596\u2013604","journal-title":"Nat Genet"},{"key":"444_CR36","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng2061","volume":"39","author":"M Parkes","year":"2007","unstructured":"Parkes M, Barrett JC, Prescott NJ et al (2007) Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn\u2019s disease susceptibility. Nat Genet 39:830\u20132","journal-title":"Nat Genet"},{"key":"444_CR37","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/ng.215","volume":"40","author":"SA McCarroll","year":"2008","unstructured":"McCarroll SA, Huett A, Kuballa P et al (2008) Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn\u2019s disease. Nat Genet 40:1107\u201312","journal-title":"Nat Genet"},{"key":"444_CR38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nature07416","volume":"456","author":"K Cadwell","year":"2008","unstructured":"Cadwell K, Liu JY, Brown SL et al (2008) A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456:259\u201363","journal-title":"Nature"},{"key":"444_CR39","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.cell.2010.05.009","volume":"141","author":"K Cadwell","year":"2010","unstructured":"Cadwell K, Patel KK, Maloney NS et al (2010) Virus-plus-susceptibility gene interaction determines Crohn\u2019s disease gene Atg16L1 phenotypes in intestine. Cell 141:1135\u201345","journal-title":"Cell"},{"key":"444_CR40","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/ibd.21275","volume":"16","author":"G Lawlor","year":"2010","unstructured":"Lawlor G, Moss AC (2010) Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander? Inflamm Bowel Dis 16:1620\u20137","journal-title":"Inflamm Bowel Dis"},{"key":"444_CR41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0002-9440(10)64516-6","volume":"157","author":"T Spieker","year":"2000","unstructured":"Spieker T, Herbst H (2000) Distribution and phenotype of Epstein-Barr virus-infected cells in inflammatory bowel disease. Am J Pathol 157:51\u20137","journal-title":"Am J Pathol"},{"key":"444_CR42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jcv.2010.09.011","volume":"50","author":"S Sankaran-Walters","year":"2011","unstructured":"Sankaran-Walters S, Ransibrahmanakul K, Grishina I et al (2011) Epstein-Barr virus replication linked to B cell proliferation in inflamed areas of colonic mucosa of patients with inflammatory bowel disease. J Clin Virol: Off Publ Pan Am Soc Clin Virol 50:31\u20136","journal-title":"J Clin Virol: Off Publ Pan Am Soc Clin Virol"},{"key":"444_CR43","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1128\/JCM.00706-08","volume":"47","author":"L Pironi","year":"2009","unstructured":"Pironi L, Bonvicini F, Gionchetti P et al (2009) Parvovirus b19 infection localized in the intestinal mucosa and associated with severe inflammatory bowel disease. J Clin Microbiol 47:1591\u20135","journal-title":"J Clin Microbiol"},{"key":"444_CR44","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nri3684","volume":"14","author":"DM Underhill","year":"2014","unstructured":"Underhill DM, Iliev ID (2014) The mycobiota: interactions between commensal fungi and the host immune system. Nat Rev Immunol 14:405\u201316","journal-title":"Nat Rev Immunol"},{"key":"444_CR45","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/00365520801935434","volume":"43","author":"SJ Ott","year":"2008","unstructured":"Ott SJ, Kuhbacher T, Musfeldt M et al (2008) Fungi and inflammatory bowel diseases: alterations of composition and diversity. Scand J Gastroenterol 43:831\u201341","journal-title":"Scand J Gastroenterol"},{"key":"444_CR46","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.mib.2013.05.004","volume":"16","author":"ID Iliev","year":"2013","unstructured":"Iliev ID, Underhill DM (2013) Striking a balance: fungal commensalism versus pathogenesis. Curr Opin Microbiol 16:366\u201373","journal-title":"Curr Opin Microbiol"},{"key":"444_CR47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nri1745","volume":"6","author":"GD Brown","year":"2006","unstructured":"Brown GD (2006) Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol 6:33\u201343","journal-title":"Nat Rev Immunol"},{"key":"444_CR48","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ni1408","volume":"8","author":"PR Taylor","year":"2007","unstructured":"Taylor PR, Tsoni SV, Willment JA et al (2007) Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat Immunol 8:31\u20138","journal-title":"Nat Immunol"},{"key":"444_CR49","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nature04926","volume":"442","author":"O Gross","year":"2006","unstructured":"Gross O, Gewies A, Finger K et al (2006) Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 442:651\u20136","journal-title":"Nature"},{"key":"444_CR50","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1056\/NEJMoa0901053","volume":"361","author":"B Ferwerda","year":"2009","unstructured":"Ferwerda B, Ferwerda G, Plantinga TS et al (2009) Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 361:1760\u20137","journal-title":"N Engl J Med"},{"key":"444_CR51","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1056\/NEJMoa0810719","volume":"361","author":"EO Glocker","year":"2009","unstructured":"Glocker EO, Hennigs A, Nabavi M et al (2009) A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 361:1727\u201335","journal-title":"N Engl J Med"},{"key":"444_CR52","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/gut.46.1.58","volume":"46","author":"CL Sutton","year":"2000","unstructured":"Sutton CL, Yang H, Li Z, Rotter JI, Targan SR, Braun J (2000) Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn\u2019s disease. Gut 46:58\u201363","journal-title":"Gut"},{"key":"444_CR53","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/ajg.2009.79","volume":"104","author":"CH Seow","year":"2009","unstructured":"Seow CH, Stempak JM, Xu W et al (2009) Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype. Am J Gastroenterol 104:1426\u201334","journal-title":"Am J Gastroenterol"},{"key":"444_CR54","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1365-2249.2003.02392.x","volume":"135","author":"LJ Walker","year":"2004","unstructured":"Walker LJ, Aldhous MC, Drummond HE et al (2004) Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn\u2019s disease are associated with disease severity but not NOD2\/CARD15 mutations. Clin Exp Immunol 135:490\u20136","journal-title":"Clin Exp Immunol"},{"key":"444_CR55","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/ng.549","volume":"42","author":"DP McGovern","year":"2010","unstructured":"McGovern DP, Gardet A, Torkvist L et al (2010) Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet 42:332\u20137","journal-title":"Nat Genet"},{"key":"444_CR56","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.ajhg.2008.03.016","volume":"82","author":"A Zhernakova","year":"2008","unstructured":"Zhernakova A, Festen EM, Franke L et al (2008) Genetic analysis of innate immunity in Crohn\u2019s disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP. Am J Hum Genet 82:1202\u201310","journal-title":"Am J Hum Genet"},{"key":"444_CR57","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1221789","volume":"336","author":"ID Iliev","year":"2012","unstructured":"Iliev ID, Funari VA, Taylor KD et al (2012) Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 336:1314\u20137","journal-title":"Science"},{"key":"444_CR58","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","volume":"13","author":"B Oppmann","year":"2000","unstructured":"Oppmann B, Lesley R, Blom B et al (2000) Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715\u201325","journal-title":"Immunity"},{"key":"444_CR59","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nri1648","volume":"5","author":"CA Hunter","year":"2005","unstructured":"Hunter CA (2005) New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 5:521\u201331","journal-title":"Nat Rev Immunol"},{"key":"444_CR60","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nri2295","volume":"8","author":"C Dong","year":"2008","unstructured":"Dong C (2008) TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 8:337\u201348","journal-title":"Nat Rev Immunol"},{"key":"444_CR61","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1056\/NEJMoa033402","volume":"351","author":"PJ Mannon","year":"2004","unstructured":"Mannon PJ, Fuss IJ, Mayer L et al (2004) Anti-interleukin-12 antibody for active Crohn\u2019s disease. N Engl J Med 351:2069\u201379","journal-title":"N Engl J Med"},{"key":"444_CR62","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/nature08949","volume":"464","author":"S Buonocore","year":"2010","unstructured":"Buonocore S, Ahern PP, Uhlig HH et al (2010) Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464:1371\u20135","journal-title":"Nature"},{"key":"444_CR63","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1053\/j.gastro.2008.07.014","volume":"135","author":"WJ Sandborn","year":"2008","unstructured":"Sandborn WJ, Feagan BG, Fedorak RN et al (2008) A randomized trial of Ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with moderate-to-severe Crohn\u2019s disease. Gastroenterology 135:1130\u201341","journal-title":"Gastroenterology"},{"key":"444_CR64","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0140-6736(08)60726-6","volume":"371","author":"KA Papp","year":"2008","unstructured":"Papp KA, Langley RG, Lebwohl M et al (2008) Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2). Lancet 371:1675\u201384","journal-title":"Lancet"},{"key":"444_CR65","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1172\/JCI21404","volume":"116","author":"D Yen","year":"2006","unstructured":"Yen D, Cheung J, Scheerens H et al (2006) IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 116:1310\u20136","journal-title":"J Clin Invest"},{"key":"444_CR66","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.immuni.2010.08.010","volume":"33","author":"PP Ahern","year":"2010","unstructured":"Ahern PP, Schiering C, Buonocore S et al (2010) Interleukin-23 drives intestinal inflammation through direct activity on T cells. Immunity 33:279\u201388","journal-title":"Immunity"},{"key":"444_CR67","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1053\/j.gastro.2011.05.052","volume":"141","author":"T Sujino","year":"2011","unstructured":"Sujino T, Kanai T, Ono Y et al (2011) Regulatory T cells suppress development of colitis, blocking differentiation of T-helper 17 into alternative T-helper 1 cells. Gastroenterology 141:1014\u201323","journal-title":"Gastroenterology"},{"key":"444_CR68","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature09447","volume":"467","author":"K Ghoreschi","year":"2010","unstructured":"Ghoreschi K, Laurence A, Yang XP et al (2010) Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 467:967\u201371","journal-title":"Nature"},{"key":"444_CR69","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.4049\/jimmunol.1201966","volume":"189","author":"S Salehi","year":"2012","unstructured":"Salehi S, Bankoti R, Benevides L et al (2012) B lymphocyte-induced maturation protein-1 contributes to intestinal mucosa homeostasis by limiting the number of IL-17-producing CD4+ T cells. J Immunol 189:5682\u201393","journal-title":"J Immunol"},{"key":"444_CR70","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.immuni.2004.08.018","volume":"21","author":"JK Kolls","year":"2004","unstructured":"Kolls JK, Linden A (2004) Interleukin-17 family members and inflammation. Immunity 21:467\u201376","journal-title":"Immunity"},{"key":"444_CR71","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/01.MIB.0000218764.06959.91","volume":"12","author":"Z Zhang","year":"2006","unstructured":"Zhang Z, Zheng M, Bindas J, Schwarzenberger P, Kolls JK (2006) Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis 12:382\u20138","journal-title":"Inflamm Bowel Dis"},{"key":"444_CR72","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1053\/j.gastro.2007.03.104","volume":"132","author":"CO Elson","year":"2007","unstructured":"Elson CO, Cong Y, Weaver CT et al (2007) Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology 132:2359\u201370","journal-title":"Gastroenterology"},{"key":"444_CR73","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1084\/jem.20061082","volume":"203","author":"MC Kullberg","year":"2006","unstructured":"Kullberg MC, Jankovic D, Feng CG et al (2006) IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J Exp Med 203:2485\u201394","journal-title":"J Exp Med"},{"key":"444_CR74","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.4049\/jimmunol.177.5.2760","volume":"177","author":"C Becker","year":"2006","unstructured":"Becker C, Dornhoff H, Neufert C et al (2006) Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis. J Immunol 177:2760\u20134","journal-title":"J Immunol"},{"key":"444_CR75","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/ni.1736","volume":"10","author":"W O\u2019Connor Jr","year":"2009","unstructured":"O\u2019Connor W Jr, Kamanaka M, Booth CJ et al (2009) A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol 10:603\u20139","journal-title":"Nat Immunol"},{"key":"444_CR76","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clim.2003.09.013","volume":"110","author":"A Ogawa","year":"2004","unstructured":"Ogawa A, Andoh A, Araki Y, Bamba T, Fujiyama Y (2004) Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin Immunol 110:55\u201362","journal-title":"Clin Immunol"},{"key":"444_CR77","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","volume":"139","author":"II Ivanov","year":"2009","unstructured":"Ivanov II, Atarashi K, Manel N et al (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485\u201398","journal-title":"Cell"},{"key":"444_CR78","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli E, Carrier Y, Gao W et al (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235\u20138","journal-title":"Nature"},{"key":"444_CR79","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1053\/j.gastro.2010.12.002","volume":"140","author":"Z Hovhannisyan","year":"2011","unstructured":"Hovhannisyan Z, Treatman J, Littman DR, Mayer L (2011) Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology 140:957\u201365","journal-title":"Gastroenterology"},{"key":"444_CR80","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1053\/j.gastro.2009.07.049","volume":"137","author":"A Sakuraba","year":"2009","unstructured":"Sakuraba A, Sato T, Kamada N, Kitazume M, Sugita A, Hibi T (2009) Th1\/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn\u2019s disease. Gastroenterology 137:1736\u201345","journal-title":"Gastroenterology"},{"key":"444_CR81","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni.2416","volume":"13","author":"Y Lee","year":"2012","unstructured":"Lee Y, Awasthi A, Yosef N et al (2012) Induction and molecular signature of pathogenic TH17 cells. Nat Immunol 13:991\u20139","journal-title":"Nat Immunol"},{"key":"444_CR82","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/ibd.20855","volume":"15","author":"DP McGovern","year":"2009","unstructured":"McGovern DP, Rotter JI, Mei L et al (2009) Genetic epistasis of IL23\/IL17 pathway genes in Crohn\u2019s disease. Inflamm Bowel Dis 15:883\u20139","journal-title":"Inflamm Bowel Dis"},{"key":"444_CR83","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/ibd.20475","volume":"14","author":"V Holtta","year":"2008","unstructured":"Holtta V, Klemetti P, Sipponen T et al (2008) IL-23\/IL-17 immunity as a hallmark of Crohn\u2019s disease. Inflamm Bowel Dis 14:1175\u201384","journal-title":"Inflamm Bowel Dis"},{"key":"444_CR84","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ibd.20339","volume":"14","author":"J Seiderer","year":"2008","unstructured":"Seiderer J, Elben I, Diegelmann J et al (2008) Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn\u2019s disease and analysis of the IL17F p.His161Arg polymorphism in IBD. Inflamm Bowel Dis 14:437\u201345","journal-title":"Inflamm Bowel Dis"},{"key":"444_CR85","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s11894-008-0104-x","volume":"10","author":"DQ Shih","year":"2008","unstructured":"Shih DQ, Targan SR, McGovern D (2008) Recent advances in IBD pathogenesis: genetics and immunobiology. Curr Gastroenterol Rep 10:568\u201375","journal-title":"Curr Gastroenterol Rep"},{"key":"444_CR86","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/mi.2010.70","volume":"4","author":"VY Taraban","year":"2011","unstructured":"Taraban VY, Slebioda TJ, Willoughby JE et al (2011) Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia. Mucosal Immunol 4:186\u201396","journal-title":"Mucosal Immunol"},{"key":"444_CR87","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.4049\/jimmunol.178.7.4033","volume":"178","author":"JL Prehn","year":"2007","unstructured":"Prehn JL, Thomas LS, Landers CJ, Yu QT, Michelsen KS, Targan SR (2007) The T cell costimulator TL1A is induced by FcgammaR signaling in human monocytes and dendritic cells. J Immunol 178:4033\u20138","journal-title":"J Immunol"},{"key":"444_CR88","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1002\/eji.200839087","volume":"39","author":"DQ Shih","year":"2009","unstructured":"Shih DQ, Kwan LY, Chavez V et al (2009) Microbial induction of inflammatory bowel disease associated gene TL1A (TNFSF15) in antigen presenting cells. Eur J Immunol 39:3239\u201350","journal-title":"Eur J Immunol"},{"key":"444_CR89","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.immuni.2008.04.021","volume":"29","author":"F Meylan","year":"2008","unstructured":"Meylan F, Davidson TS, Kahle E et al (2008) The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Immunity 29:79\u201389","journal-title":"Immunity"},{"key":"444_CR90","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/ibd.21124","volume":"16","author":"N Kamada","year":"2010","unstructured":"Kamada N, Hisamatsu T, Honda H et al (2010) TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohn\u2019s disease. Inflamm Bowel Dis 16:568\u201375","journal-title":"Inflamm Bowel Dis"},{"key":"444_CR91","unstructured":"Endo K, Kinouchi Y, Kakuta Y, Ueki N, Takahashi S, Shimosegawa T (2009) Involvement of NF-kappa B pathway in TL1A gene expression induced by lipopolysaccharide. Cytokine 2009"},{"key":"444_CR92","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1053\/j.gastro.2008.04.037","volume":"135","author":"H Takedatsu","year":"2008","unstructured":"Takedatsu H, Michelsen KS, Wei B et al (2008) TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology 135:552\u201367","journal-title":"Gastroenterology"},{"key":"444_CR93","author":"DQ Shih","year":"2014","unstructured":"Shih DQ, Zheng L, Zhang X et al (2014) Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis. Mucosal Immunol. doi: 10.1038\/mi.2014.34","journal-title":"Mucosal Immunol"},{"key":"444_CR94","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1096\/fj.10-166843","volume":"25","author":"GW Jones","year":"2011","unstructured":"Jones GW, Stumhofer JS, Foster T et al (2011) Naive and activated T cells display differential responsiveness to TL1A that affects Th17 generation, maintenance, and proliferation. FASEB J: Off Publ Fed Am Soc Exp Biol 25:409\u201319","journal-title":"FASEB J: Off Publ Fed Am Soc Exp Biol"},{"key":"444_CR95","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nature07036","volume":"453","author":"E Bettelli","year":"2008","unstructured":"Bettelli E, Korn T, Oukka M, Kuchroo VK (2008) Induction and effector functions of T(H)17 cells. Nature 453:1051\u20137","journal-title":"Nature"},{"key":"444_CR96","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","volume":"24","author":"M Veldhoen","year":"2006","unstructured":"Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179\u201389","journal-title":"Immunity"},{"key":"444_CR97","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature04754","volume":"441","author":"PR Mangan","year":"2006","unstructured":"Mangan PR, Harrington LE, O\u2019Quinn DB et al (2006) Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441:231\u20134","journal-title":"Nature"},{"key":"444_CR98","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJMoa1109997","volume":"366","author":"C Leonardi","year":"2012","unstructured":"Leonardi C, Matheson R, Zachariae C et al (2012) Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N Engl J Med 366:1190\u20139","journal-title":"N Engl J Med"},{"key":"444_CR99","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","volume":"61","author":"W Hueber","year":"2012","unstructured":"Hueber W, Sands BE, Lewitzky S et al (2012) Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn\u2019s disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut 61:1693\u2013700","journal-title":"Gut"},{"key":"444_CR100","doi-asserted-by":"crossref","first-page":"S-133","DOI":"10.1016\/S0016-5085(14)60471-6","volume":"146","author":"ZL Wallace KL","year":"2014","unstructured":"Wallace KL ZL, Kanazawa Y, Zhang H, Ichikawa R, Chen J, Sidhu M, Zhang X, Pothoulakis C, Koon HW, Targan S, Shih DQ (2014) Tl1a modulates the differential effect of IL-17 blockade on mucosal inflammation. Gastroenterology 146:S-133","journal-title":"Gastroenterology"},{"key":"444_CR101","doi-asserted-by":"crossref","first-page":"e4719","DOI":"10.1371\/journal.pone.0004719","volume":"4","author":"KS Michelsen","year":"2009","unstructured":"Michelsen KS, Thomas LS, Taylor KD et al (2009) IBD-associated TL1A gene (TNFSF15) haplotypes determine increased expression of TL1A protein. PLoS One 4:e4719","journal-title":"PLoS One"}],"container-title":["Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-014-0444-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00281-014-0444-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-014-0444-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T10:12:13Z","timestamp":1559038333000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00281-014-0444-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":101,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["444"],"URL":"https:\/\/doi.org\/10.1007\/s00281-014-0444-6","relation":{},"ISSN":["1863-2297","1863-2300"],"issn-type":[{"value":"1863-2297","type":"print"},{"value":"1863-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}